Multicentric Randomized Phase III Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus 5-fluorouracil, Leucovorin, Irinotecan and Oxaliplatin (mFolfirinox) in Patients With Resected Pancreatic Adenocarcinoma
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Gemcitabine (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors UNICANCER
- 24 Jan 2017 Planned End Date changed from 1 Jan 2020 to 1 Sep 2021.
- 24 Jan 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Sep 2018.
- 24 Jan 2017 Status changed from recruiting to active, no longer recruiting.